Imaging in pleural mesothelioma: A review of Imaging Research Presented at the 9th International Meeting of the International Mesothelioma Interest Group-Reference-Cited by-同舟云学术

Imaging in pleural mesothelioma: A review of Imaging Research Presented at the 9th International Meeting of the International Mesothelioma Interest Group

Published:2010-10 Issue:1 Volume:70 Page:1-6
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Nowak Anna K.,Armato Samuel G.,Ceresoli Giovanni Luca,Yildirim Huseyin,Francis Roslyn J.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference22 articles.

1. Modified RECIST criteria for assessment of response in malignant pleural mesothelioma;Byrne;Ann Oncol,2004

2. New guidelines to evaluate the response to treatment in solid tumors;Therasse;J Natl Cancer Inst,2000

3. Malignant mesothelioma 2008;Zervos;Curr Opin Pulm Med,2008

4. Computed tomography features in malignant pleural mesothelioma and other commonly seen pleural diseases;Metintas;Eur J Radiol,2002

5. The role of Abrams percutaneous pleural biopsy in the investigation of exudative pleural effusions;Chakrabarti;Chest,2006

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fibroblast Activation Protein–Directed Imaging Outperforms¹⁸F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational Trial;Journal of Nuclear Medicine;2024-07-03

2. Diagnostic Applications of Nuclear Medicine: Lung and Mediastinal Tumors;Nuclear Oncology;2022

3. Malignes Pleuramesotheliom;Diagnostic Imaging: Onkologie;2022

4. Diagnostic Applications of Nuclear Medicine: Lung and Mediastinal Tumors;Nuclear Oncology;2022

5. Diagnostic Applications of Nuclear Medicine: Lung and Mediastinal Tumors;Nuclear Oncology;2022